Literature DB >> 21589542

(2R,4R)-1-(tert-But-oxy-carbon-yl)-4-meth-oxy-pyrrolidine-2-carb-oxy-lic acid.

Jing Yuan, Zhi-Qiang Cai, Chang-Jiang Huang, Wei-Ren Xu.   

Abstract

In the title compound, C(11)H(19)NO(5), the five-membered pyrrolidine ring adopts an envelope conformation. The dihedral angles between the carboxyl group plane, the pyrrolidine ring and the meth-oxy group are 59.50 (3) and 62.02 (1)°, respectively. In the crystal, inter-molecular O-H⋯O hydrogen bonds link the mol-ecules into chains along [100]. The absolute configuration is assigned in accord with that of (2R,4R)-1-(tert-but-oxy-carbon-yl)-4-hy-droxy-pyrrolidine-2-carb-oxy-lic acid, which was the starting material in the synthesis.

Entities:  

Year:  2010        PMID: 21589542      PMCID: PMC3011444          DOI: 10.1107/S1600536810047707

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

The title compound is an inter­mediate in the preparation of the direct FXa inhibitor, eribaxaban {systematic name: (2R,4R)-N 1-(4-chlorophenyl)-N 2-[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide}. For background to the bioactivity and applications of eribaxaban, see: Perzborn (2009 ▶); Kohrt et al. (2007 ▶). For the synthesis of other derivatives with proline, see: Van Huis et al. (2009 ▶); Bigge et al. (2003 ▶).

Experimental

Crystal data

C11H19NO5 M = 245.27 Monoclinic, a = 6.4299 (13) Å b = 9.784 (2) Å c = 10.279 (2) Å β = 90.12 (3)° V = 646.7 (2) Å3 Z = 2 Mo Kα radiation μ = 0.10 mm−1 T = 293 K 0.26 × 0.20 × 0.10 mm

Data collection

Rigaku Saturn CCD area-detector diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005) ▶ T min = 0.975, T max = 0.990 7923 measured reflections 1601 independent reflections 1059 reflections with I > 2σ(I) R int = 0.059

Refinement

R[F 2 > 2σ(F 2)] = 0.037 wR(F 2) = 0.086 S = 0.94 1601 reflections 163 parameters 1 restraint H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.13 e Å−3 Δρmin = −0.16 e Å−3 Data collection: CrystalClear (Rigaku, 2005) ▶; cell refinement: CrystalClear ▶; data reduction: CrystalClear ▶; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536810047707/kp2285sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810047707/kp2285Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C11H19NO5F(000) = 264
Mr = 245.27Dx = 1.260 Mg m3
Monoclinic, P21Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P2ybCell parameters from 1953 reflections
a = 6.4299 (13) Åθ = 3.2–27.8°
b = 9.784 (2) ŵ = 0.10 mm1
c = 10.279 (2) ÅT = 293 K
β = 90.12 (3)°Prism, colorless
V = 646.7 (2) Å30.26 × 0.20 × 0.10 mm
Z = 2
Rigaku Saturn CCD area-detector diffractometer1601 independent reflections
Radiation source: rotating anode1059 reflections with I > 2σ(I)
confocalRint = 0.059
ω and φ scansθmax = 27.7°, θmin = 3.2°
Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005)h = −8→8
Tmin = 0.975, Tmax = 0.990k = −12→12
7923 measured reflectionsl = −13→13
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.037H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.086w = 1/[σ2(Fo2) + (0.0494P)2] where P = (Fo2 + 2Fc2)/3
S = 0.94(Δ/σ)max < 0.001
1601 reflectionsΔρmax = 0.13 e Å3
163 parametersΔρmin = −0.16 e Å3
1 restraintExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.55 (4)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.9616 (2)0.74085 (17)0.56702 (14)0.0482 (4)
O21.2349 (3)0.63017 (18)0.30520 (17)0.0550 (5)
O31.1022 (3)0.83878 (17)0.27707 (17)0.0505 (5)
H31.253 (5)0.861 (4)0.262 (3)0.093 (11)*
O40.4931 (2)0.92660 (17)0.24970 (16)0.0472 (5)
O50.6949 (2)0.80182 (16)0.10995 (13)0.0462 (5)
N10.7106 (2)0.7625 (2)0.32240 (16)0.0387 (4)
C11.0873 (3)0.7059 (2)0.2972 (2)0.0383 (5)
C20.8634 (3)0.6534 (2)0.3036 (2)0.0375 (5)
H20.83040.60190.22440.045*
C30.8259 (4)0.5636 (2)0.4235 (2)0.0490 (6)
H3A0.70870.50270.41030.059*
H3B0.94820.50990.44480.059*
C40.7804 (4)0.6680 (2)0.5283 (2)0.0461 (6)
H40.70920.62690.60280.055*
C50.6428 (3)0.7725 (3)0.45841 (19)0.0454 (6)
H5A0.49680.74930.46700.054*
H5B0.66540.86380.49240.054*
C61.1031 (4)0.6610 (3)0.6413 (2)0.0632 (8)
H6A1.02890.61350.70840.095*
H6B1.20570.71970.68010.095*
H6C1.17060.59600.58560.095*
C70.6240 (3)0.8376 (2)0.2284 (2)0.0381 (5)
C80.6706 (4)0.8926 (2)−0.0042 (2)0.0463 (6)
C90.7760 (5)1.0273 (3)0.0251 (3)0.0712 (9)
H9A0.70981.06970.09830.107*
H9B0.76501.0863−0.04930.107*
H9C0.92001.01150.04470.107*
C100.7858 (5)0.8146 (4)−0.1077 (2)0.0734 (9)
H10A0.92560.7975−0.07910.110*
H10B0.78840.8672−0.18650.110*
H10C0.71670.7291−0.12350.110*
C110.4450 (5)0.9100 (4)−0.0410 (3)0.0750 (9)
H11A0.37650.8229−0.03820.113*
H11B0.43560.9469−0.12740.113*
H11C0.37940.97140.01910.113*
U11U22U33U12U13U23
O10.0579 (10)0.0464 (10)0.0402 (8)−0.0032 (8)−0.0090 (7)0.0051 (7)
O20.0423 (9)0.0491 (10)0.0735 (11)0.0155 (9)−0.0065 (7)−0.0084 (8)
O30.0326 (9)0.0405 (10)0.0783 (12)0.0026 (8)0.0053 (7)0.0105 (9)
O40.0349 (9)0.0452 (10)0.0614 (10)0.0048 (8)0.0058 (7)0.0067 (7)
O50.0514 (9)0.0497 (10)0.0374 (9)0.0110 (8)−0.0016 (6)0.0051 (7)
N10.0300 (9)0.0469 (11)0.0393 (10)0.0032 (9)0.0017 (7)0.0045 (8)
C10.0368 (13)0.0415 (13)0.0364 (11)0.0045 (10)−0.0013 (9)−0.0039 (9)
C20.0378 (11)0.0365 (12)0.0384 (11)−0.0004 (10)−0.0062 (8)−0.0033 (9)
C30.0561 (16)0.0360 (13)0.0548 (14)−0.0073 (11)−0.0064 (11)0.0074 (10)
C40.0509 (14)0.0451 (15)0.0424 (12)−0.0089 (11)0.0027 (10)0.0084 (10)
C50.0411 (12)0.0557 (15)0.0393 (12)−0.0021 (12)0.0076 (9)0.0029 (11)
C60.0698 (17)0.073 (2)0.0469 (15)0.0031 (16)−0.0158 (12)0.0085 (13)
C70.0270 (10)0.0422 (13)0.0451 (12)−0.0051 (10)0.0012 (9)0.0042 (10)
C80.0563 (15)0.0457 (14)0.0367 (12)−0.0018 (11)−0.0070 (10)0.0064 (9)
C90.100 (2)0.0617 (19)0.0519 (16)−0.0284 (18)0.0041 (15)0.0033 (13)
C100.103 (2)0.076 (2)0.0412 (14)0.0196 (19)0.0010 (14)0.0007 (14)
C110.072 (2)0.076 (2)0.078 (2)0.0082 (17)−0.0301 (15)0.0039 (16)
O1—C61.421 (3)C4—H40.9800
O1—C41.422 (3)C5—H5A0.9700
O2—C11.206 (3)C5—H5B0.9700
O3—C11.320 (3)C6—H6A0.9600
O3—H31.00 (3)C6—H6B0.9600
O4—C71.231 (3)C6—H6C0.9600
O5—C71.347 (3)C8—C101.506 (3)
O5—C81.480 (3)C8—C111.508 (4)
N1—C71.335 (3)C8—C91.512 (4)
N1—C21.464 (3)C9—H9A0.9600
N1—C51.469 (3)C9—H9B0.9600
C1—C21.530 (3)C9—H9C0.9600
C2—C31.533 (3)C10—H10A0.9600
C2—H20.9800C10—H10B0.9600
C3—C41.513 (3)C10—H10C0.9600
C3—H3A0.9700C11—H11A0.9600
C3—H3B0.9700C11—H11B0.9600
C4—C51.530 (3)C11—H11C0.9600
C6—O1—C4113.5 (2)O1—C6—H6A109.5
C1—O3—H3108 (2)O1—C6—H6B109.5
C7—O5—C8121.67 (18)H6A—C6—H6B109.5
C7—N1—C2125.79 (17)O1—C6—H6C109.5
C7—N1—C5121.89 (19)H6A—C6—H6C109.5
C2—N1—C5112.03 (17)H6B—C6—H6C109.5
O2—C1—O3123.9 (2)O4—C7—N1123.01 (19)
O2—C1—C2122.1 (2)O4—C7—O5125.3 (2)
O3—C1—C2113.93 (19)N1—C7—O5111.70 (19)
N1—C2—C1113.13 (18)O5—C8—C10101.8 (2)
N1—C2—C3101.81 (17)O5—C8—C11111.5 (2)
C1—C2—C3112.11 (17)C10—C8—C11110.7 (2)
N1—C2—H2109.8O5—C8—C9108.62 (19)
C1—C2—H2109.8C10—C8—C9111.2 (2)
C3—C2—H2109.8C11—C8—C9112.5 (2)
C4—C3—C2102.49 (18)C8—C9—H9A109.5
C4—C3—H3A111.3C8—C9—H9B109.5
C2—C3—H3A111.3H9A—C9—H9B109.5
C4—C3—H3B111.3C8—C9—H9C109.5
C2—C3—H3B111.3H9A—C9—H9C109.5
H3A—C3—H3B109.2H9B—C9—H9C109.5
O1—C4—C3112.24 (19)C8—C10—H10A109.5
O1—C4—C5105.62 (19)C8—C10—H10B109.5
C3—C4—C5103.28 (17)H10A—C10—H10B109.5
O1—C4—H4111.7C8—C10—H10C109.5
C3—C4—H4111.7H10A—C10—H10C109.5
C5—C4—H4111.7H10B—C10—H10C109.5
N1—C5—C4103.27 (19)C8—C11—H11A109.5
N1—C5—H5A111.1C8—C11—H11B109.5
C4—C5—H5A111.1H11A—C11—H11B109.5
N1—C5—H5B111.1C8—C11—H11C109.5
C4—C5—H5B111.1H11A—C11—H11C109.5
H5A—C5—H5B109.1H11B—C11—H11C109.5
C7—N1—C2—C185.8 (2)C7—N1—C5—C4179.02 (19)
C5—N1—C2—C1−100.3 (2)C2—N1—C5—C44.8 (2)
C7—N1—C2—C3−153.7 (2)O1—C4—C5—N189.6 (2)
C5—N1—C2—C320.2 (2)C3—C4—C5—N1−28.4 (2)
O2—C1—C2—N1166.64 (19)C2—N1—C7—O4178.7 (2)
O3—C1—C2—N1−16.0 (2)C5—N1—C7—O45.3 (3)
O2—C1—C2—C352.2 (3)C2—N1—C7—O5−0.3 (3)
O3—C1—C2—C3−130.4 (2)C5—N1—C7—O5−173.6 (2)
N1—C2—C3—C4−37.2 (2)C8—O5—C7—O418.7 (3)
C1—C2—C3—C484.0 (2)C8—O5—C7—N1−162.41 (18)
C6—O1—C4—C3−71.9 (2)C7—O5—C8—C10175.9 (2)
C6—O1—C4—C5176.29 (19)C7—O5—C8—C11−65.9 (3)
C2—C3—C4—O1−72.3 (2)C7—O5—C8—C958.5 (3)
C2—C3—C4—C540.9 (2)
D—H···AD—HH···AD···AD—H···A
O3—H3···O4i1.00 (3)1.68 (4)2.672 (2)169 (4)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
O3—H3⋯O4i1.00 (3)1.68 (4)2.672 (2)169 (4)

Symmetry code: (i) .

  4 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action.

Authors:  Chad A Van Huis; Agustin Casimiro-Garcia; Christopher F Bigge; Wayne L Cody; Danette A Dudley; Kevin J Filipski; Ronald J Heemstra; Jeffrey T Kohrt; Robert J Leadley; Lakshmi S Narasimhan; Thomas McClanahan; Igor Mochalkin; Michael Pamment; J Thomas Peterson; Vaishali Sahasrabudhe; Robert P Schaum; Jeremy J Edmunds
Journal:  Bioorg Med Chem       Date:  2009-02-03       Impact factor: 3.641

3.  Factor Xa inhibitors--new anticoagulants for secondary haemostasis.

Authors:  E Perzborn
Journal:  Hamostaseologie       Date:  2009-08       Impact factor: 1.778

4.  The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor.

Authors:  Jeffrey T Kohrt; Christopher F Bigge; John W Bryant; Agustin Casimiro-Garcia; Liguo Chi; Wayne L Cody; Tawny Dahring; Danette A Dudley; Kevin J Filipski; Staci Haarer; Ron Heemstra; Nancy Janiczek; Lakshmi Narasimhan; Thomas McClanahan; J Thomas Peterson; Vaisheli Sahasrabudhe; Robert Schaum; Chad A Van Huis; Kathleen M Welch; Erli Zhang; Robert J Leadley; Jeremy J Edmunds
Journal:  Chem Biol Drug Des       Date:  2007-08       Impact factor: 2.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.